Full-Time
Clinical Conduct Specialist
Adme
Confirmed live in the last 24 hours
Celerion
1,001-5,000 employees
Clinical research organization for drug development
Entry, Junior
Lincoln, NE, USA
Position requires onsite presence in Lincoln, NE.
- Post high school education in life sciences or medical training preferred
- At least 6 months of internal experience preferred
- Must be able to handle multiple priorities
- Effective written and verbal communication
- Organizational skills
- Experience working in a medical environment preferred
- assisting Clinical Study Managers with study preparation and set up
- work closely with conduct staff to ensure they are trained on study specific duties
- responsible for ordering medical supplies for study set up
- preparing clinic flow for smooth conduct
- providing leadership to the team
- participate in client meetings
- Process/extract radioactive ADME samples (feces, urine, blood, plasma) for analysis
- Perform pre-study setup activities (i.e. reagent preparation, equipment maintenance, order supplies, source documents)
- Accurately transfer, pipet, and weigh samples for analysis
- Record and document test data in notebooks/binders/electronic notebooks
- Perform QC function on notebook/binder/electronic notebook documentation
- Sample shipment and destruction once sponsor approval has been received
- Keep the lab clean and organized
- Ability to work in required work environment, including but not limited to working in a clinical / laboratory environment with exposure to biological / biohazardous materials and second hand smoke from combustible cigarettes and vapors from electronic cigarettes
Celerion specializes in early phase drug development as a clinical research organization (CRO). The company provides a range of services to pharmaceutical and biotechnology companies, including clinical trial design, feasibility studies, project management, and regulatory affairs. Celerion uses advanced bioanalytical techniques, particularly High Resolution Mass Spectrometry (HR MS), for metabolite profiling and identification, which enhances their research capabilities. This focus on bioanalytical sciences and their extensive experience allows Celerion to assist clients in making informed decisions during the early stages of drug development. Unlike many competitors, Celerion emphasizes speed and quality in their research processes, aiming to help clients bring new treatments to market more quickly, ultimately benefiting patients around the world.
Company Stage
Acquired
Total Funding
N/A
Headquarters
Lincoln, Nebraska
Founded
N/A
6 month growth
↑ 11%1 year growth
↑ 11%2 year growth
↑ 13%
Simplify's Take
What believers are saying
- Celerion's expansion into GLP/GCP compliant molecular and cell biology testing positions it well to support the growing field of cell and gene therapies.
- The appointment of Jo Goodman as VP of Bioanalytical Services brings extensive industry experience, potentially driving innovation and enhancing service delivery.
- H.I.G. Capital's acquisition of Celerion could provide additional resources and strategic direction, fostering further growth and development.
What critics are saying
- The acquisition by H.I.G. Capital may lead to changes in company culture or strategic priorities, potentially causing uncertainty among employees.
- The competitive landscape of CROs requires Celerion to continuously innovate and maintain high standards to retain its leadership position.
What makes Celerion unique
- Celerion's expertise in early phase drug development and advanced bioanalytical sciences, particularly in metabolite profiling using HR MS, sets it apart from other CROs.
- The company's consistent recognition with CRO Leadership Awards highlights its reputation for quality, capabilities, and reliability in the industry.
- Celerion's recent CLIA certification enhances its bioanalytical laboratory capabilities, allowing it to conduct high-complexity testing and diagnostic services.
Help us improve and share your feedback! Did you find this helpful?